AR068419A1 - Cepas de mycoplasma atenuadas vivas - Google Patents
Cepas de mycoplasma atenuadas vivasInfo
- Publication number
- AR068419A1 AR068419A1 ARP080103957A ARP080103957A AR068419A1 AR 068419 A1 AR068419 A1 AR 068419A1 AR P080103957 A ARP080103957 A AR P080103957A AR P080103957 A ARP080103957 A AR P080103957A AR 068419 A1 AR068419 A1 AR 068419A1
- Authority
- AR
- Argentina
- Prior art keywords
- live
- mycoplasma bacteria
- atenuated
- mycoplasma
- lives
- Prior art date
Links
- 241000204031 Mycoplasma Species 0.000 title abstract 5
- 230000002238 attenuated effect Effects 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 101710088194 Dehydrogenase Proteins 0.000 abstract 1
- KKZFLSZAWCYPOC-VPENINKCSA-N Deoxyribose 5-phosphate Chemical compound O[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1 KKZFLSZAWCYPOC-VPENINKCSA-N 0.000 abstract 1
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 abstract 1
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 abstract 1
- 102000012288 Phosphopyruvate Hydratase Human genes 0.000 abstract 1
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 abstract 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 210000003705 ribosome Anatomy 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56933—Mycoplasma
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/30—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La presente proporciona bacteria Mycoplasma atenuada, viva que exhibe expresion reducida de una o más proteínas seleccionadas del grupo que consiste de piruvato deshidrogenasa, fosfopiruvato hidratasa, 2-desoxirribosa-5-fosfato aldolasa, y proteína L35 ribosomica, relacionada con una bacteria Mycoplasma tipo silvestre de la misma especie. También se proporcionan vacunas y métodos de vacunacion que involucran el uso de la bacteria Mycoplasma atenuada, viva, y métodos para hacer bacteria Mycoplasma atenuada viva.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99345607P | 2007-09-11 | 2007-09-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR068419A1 true AR068419A1 (es) | 2009-11-18 |
Family
ID=40019605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080103957A AR068419A1 (es) | 2007-09-11 | 2008-09-11 | Cepas de mycoplasma atenuadas vivas |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20090068231A1 (es) |
| EP (1) | EP2209489A1 (es) |
| JP (1) | JP2012501624A (es) |
| KR (1) | KR20100072019A (es) |
| CN (1) | CN101820902A (es) |
| AR (1) | AR068419A1 (es) |
| AU (1) | AU2008298749A1 (es) |
| BR (1) | BRPI0816686A2 (es) |
| CA (1) | CA2699367A1 (es) |
| CL (1) | CL2008002709A1 (es) |
| CO (1) | CO6270237A2 (es) |
| MX (1) | MX2010002867A (es) |
| RU (1) | RU2473682C2 (es) |
| TW (1) | TW200920397A (es) |
| WO (1) | WO2009036241A1 (es) |
| ZA (1) | ZA201002515B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110059437A1 (en) * | 2006-09-07 | 2011-03-10 | Boehringer Ingelheim Vetmedica, Inc. | Pcr-based genotyping |
| AR069087A1 (es) * | 2007-10-29 | 2009-12-30 | Boehringer Ingelheim Vetmed | Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma |
| WO2010051210A1 (en) | 2008-10-31 | 2010-05-06 | Boehringer Ingelheim Vetmedica, Inc. | Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition |
| UY32570A (es) * | 2009-04-24 | 2010-11-30 | Boehringer Ingelheim Vetmed | Vacuna viva modificada de mycoplasma bovis mejorada |
| US9260691B2 (en) | 2010-05-19 | 2016-02-16 | Bioproperties Pty Ltd | Methods relating to an attenuated mycoplasma |
| UA121097C2 (uk) | 2012-12-28 | 2020-04-10 | Бьорінгер Інгельхайм Ветмедіка Гмбх | Імуногенна композиція, що містить антигени мікоплазм |
| CN108379571A (zh) | 2012-12-28 | 2018-08-10 | 勃林格殷格翰动物保健有限公司 | 支原体疫苗的制备方法 |
| US9849168B2 (en) | 2014-01-26 | 2017-12-26 | Jiangsu Academy Of Agricultural Sciences | Attenuated live vaccine against mycoplasmal pneumonia of swine (MPS) and use thereof |
| PL3334454T3 (pl) * | 2015-08-14 | 2023-01-30 | Zoetis Services Llc | Kompozycje mycoplasma bovis |
| US10758603B2 (en) * | 2016-08-09 | 2020-09-01 | Agricultural Technology Research Institute | Composition for preventing and treating Mycoplasma hyorhinis infection, and method for producing said composition |
| CN109234418B (zh) * | 2018-11-20 | 2021-08-13 | 湖南中净生物科技有限公司 | 一种鉴别猪肺炎支原体野毒株和疫苗株的引物、试剂盒和方法 |
| CN111172083A (zh) * | 2020-03-06 | 2020-05-19 | 北京龙科方舟生物工程技术有限公司 | 一种用于高密度培养山羊支原体山羊肺炎亚种的培养基及其发酵培养方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2058237T3 (es) * | 1987-09-18 | 1994-11-01 | Akzo Nv | Metodo para la preparacion de una vacuna para combatir la infeccion mycoplasmica en aves de corral. |
| US20020187162A1 (en) * | 2001-04-21 | 2002-12-12 | Geary Steven J. | Use of a live attenuated Mycoplasma gallisepticum strain as a vaccine and vector for the protection of chickens and turkeys from respiratory disease |
| US7217420B2 (en) * | 2002-07-13 | 2007-05-15 | The University Of Georgia Research Foundation, Inc. | Mycoplasma gallisepticum formulation |
| CL2008002675A1 (es) * | 2007-09-11 | 2008-11-07 | Wyeth Corp | Bacteria de mycoplasma gallisepticum atenuada; composicion de vacuna que la comprende; método de vacunación; y método de identificación de clones de mycoplasma gallisepticum atenuados. |
-
2008
- 2008-09-10 US US12/207,698 patent/US20090068231A1/en not_active Abandoned
- 2008-09-11 CL CL200802709A patent/CL2008002709A1/es unknown
- 2008-09-11 AR ARP080103957A patent/AR068419A1/es not_active Application Discontinuation
- 2008-09-11 TW TW097134905A patent/TW200920397A/zh unknown
- 2008-09-12 CN CN200880111517A patent/CN101820902A/zh active Pending
- 2008-09-12 BR BRPI0816686 patent/BRPI0816686A2/pt not_active IP Right Cessation
- 2008-09-12 WO PCT/US2008/076119 patent/WO2009036241A1/en not_active Ceased
- 2008-09-12 JP JP2010525016A patent/JP2012501624A/ja active Pending
- 2008-09-12 AU AU2008298749A patent/AU2008298749A1/en not_active Abandoned
- 2008-09-12 RU RU2010110447/10A patent/RU2473682C2/ru not_active IP Right Cessation
- 2008-09-12 KR KR1020107007751A patent/KR20100072019A/ko not_active Ceased
- 2008-09-12 CA CA2699367A patent/CA2699367A1/en not_active Abandoned
- 2008-09-12 MX MX2010002867A patent/MX2010002867A/es active IP Right Grant
- 2008-09-12 EP EP08830393A patent/EP2209489A1/en not_active Withdrawn
-
2010
- 2010-03-25 CO CO10035477A patent/CO6270237A2/es not_active Application Discontinuation
- 2010-04-09 ZA ZA2010/02515A patent/ZA201002515B/en unknown
-
2011
- 2011-10-28 US US13/283,815 patent/US20120045476A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0816686A2 (pt) | 2015-03-17 |
| US20090068231A1 (en) | 2009-03-12 |
| KR20100072019A (ko) | 2010-06-29 |
| US20120045476A1 (en) | 2012-02-23 |
| JP2012501624A (ja) | 2012-01-26 |
| CL2008002709A1 (es) | 2008-10-24 |
| TW200920397A (en) | 2009-05-16 |
| WO2009036241A1 (en) | 2009-03-19 |
| MX2010002867A (es) | 2010-05-24 |
| CN101820902A (zh) | 2010-09-01 |
| EP2209489A1 (en) | 2010-07-28 |
| RU2473682C2 (ru) | 2013-01-27 |
| CO6270237A2 (es) | 2011-04-20 |
| RU2010110447A (ru) | 2011-10-20 |
| AU2008298749A1 (en) | 2009-03-19 |
| ZA201002515B (en) | 2010-12-29 |
| CA2699367A1 (en) | 2009-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR068419A1 (es) | Cepas de mycoplasma atenuadas vivas | |
| AR068418A1 (es) | Bacteria mycoplasma gallisepticum atenuada, composicion de vacuna, metodos para identificar clones de mycoplasma gallisepticum atenuados y vacunar un animal contra infeccion de mycoplasma gallisepticum | |
| AR110684A1 (es) | Composiciones que comprenden cepas bacterianas y método de tratamiento | |
| DE602006015665D1 (de) | Probiotische enterokokken für eine verbesserte immunität | |
| BR112017017805A2 (pt) | composição | |
| ES3052985T3 (en) | Use of bacillus methylotrophicus strain xt1 as a stimulant of plant growth and biological control means, and isolates of said species | |
| BR112016023707A2 (pt) | método para produzir l-aminoácidos com o uso de uma bactéria alcalifílica | |
| BR112017007765A2 (pt) | composições de adenosina deaminase-2 (ada2), variantes do mesmo e métodos de usar o mesmo | |
| MX375202B (es) | Composiciones adyuvantes novedosas. | |
| BRPI1011934A8 (pt) | Composição | |
| MX2017008817A (es) | Composiciones y metodos para la glicosilacion de proteinas. | |
| MX385047B (es) | Composiciones microbianas para alimentacion directa y sus metodos de uso. | |
| AR075484A1 (es) | Pestivirus quimericos | |
| BR112016006048A8 (pt) | composições antimicrobianas | |
| BR112012028893A2 (pt) | composições imunoestimuladoras e de vacina | |
| BR112015025748A2 (pt) | construção de dna para imunomodulação, composição farmacêutica, vacina, e uso de uma construção de dna | |
| BR112015011697A2 (pt) | antibióticos macrocíclicos de amplo espectro | |
| AR092630A1 (es) | Metodos y composiciones para prevenir la incorporacion erronea de norleucina en proteinas | |
| BR112014014319A2 (pt) | composições de cuidado oral | |
| MX2018014419A (es) | Composicion y metodos para la terapia de microbiota. | |
| PE20190397A1 (es) | Virus de enteritis de pato y usos del mismo | |
| CR20150310A (es) | Solución para preservar conductos vasculares | |
| BR112017003556A2 (pt) | método de cultivo de um micro-organismo. | |
| MX2010000864A (es) | Vacuna de celulas enteras estafilococcicas inactivadas. | |
| UY31437A1 (es) | Vacuna de mycoplasma bovis y métodos de uso de la misma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |